Hologic Inc. (NSDQ:HOLX) has a $160 million deal to acquire Bolder Surgical, a developer and manufacturer of advanced energy vessel sealing surgical devices.

It’s the latest deal by Hologic, which has been spending COVID-19 test revenue generated by its diagnostics business on acquisitions across the company’s business lines, as CFO Karleen Oberton and CEO Steve MacMillan recently discussed with Medical Design & Outsourcing.

Louisville, Colorado-based Bolder Surgical’s laparoscopic vessel sealing, dividing and dissecting devices will join Hologic’s surgical portfolio when the deal closes, expected by the end of 2021.

Marlborough, Massachusetts–based Hologic plans to expand Bolder’s pediatric-focused devices to OB-GYN specialists, estimating that there are five times more laparoscopic procedures in OB-GYN applications than in pediatrics.

Get the full story on our sister site, MassDevice.